Paul S Sehdev, MD | |
9155 Sw Barnes Rd, Suite 638, Portland, OR 97225-6625 | |
(503) 216-7000 | |
(503) 216-6999 |
Full Name | Paul S Sehdev |
---|---|
Gender | Male |
Speciality | Internal Medicine - Infectious Disease |
Location | 9155 Sw Barnes Rd, Portland, Oregon |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1689607202 | NPI | - | NPPES |
286489 | Medicaid | OR | |
P00211311 | Other | OR | RR MEDICARE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RI0200X | Internal Medicine - Infectious Disease | MD19005 (Oregon) | Primary |
Mailing Address | Practice Location Address |
---|---|
Paul S Sehdev, MD Po Box 3158, Portland, OR 97208-3158 Ph: (503) 215-6494 | Paul S Sehdev, MD 9155 Sw Barnes Rd, Suite 638, Portland, OR 97225-6625 Ph: (503) 216-7000 |
News Archive
State leaders hope their mental health redesign will bring better services to (rural areas of Iowa), but many front-line administrators doubt they'll see significant improvements soon. In fact, some worry that services could erode over the next year as money and some financial responsibilities are shifted from the counties to the state. Some long-term improvements are possible, they say, but cash likely will run short in the next few months.
VIVUS, Inc. today announced that results from the SEQUEL study were published in The American Journal of Clinical Nutrition, a peer-reviewed journal with broad, multidisciplinary readership.
St. Jude Children's Research Hospital scientists have developed a web application and data set that gives researchers worldwide a powerful interactive tool to advance understanding of the mutations that lead to and fuel pediatric cancer. The freely available tool, called ProteinPaint, is described in today's issue of the scientific journal Nature Genetics.
EpiCept Corporation has announced that it has filed a New Drug Submission (NDS) with Health Canada for CepleneĀ® (histamine dihydrochloride) for the treatment of acute myeloid leukemia (AML) patients in first complete remission. Health Canada typically accepts or refuses an NDS and designates review status within forty-five days of filing. If accepted, the customary timeframe for completion of review and an approval decision is within one year.
Elsevier's MC Strategies, a leader in providing eLearning solutions to more than 1,300 healthcare organizations, today announced the continued development of its ICD-10 Roadmap with the introduction of new curricula, including a comprehensive clinical documentation curriculum.
› Verified 3 days ago
Salona Shrestha, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 4805 Ne Glisan St, Portland, OR 97213 Phone: 503-215-2392 | |
Dr. Emmanuel Trungtoan Tavan, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 2800 N Vancouver Ave, Suite 230, Portland, OR 97227 Phone: 503-413-2901 | |
Ginevra Lois Liptan, M.D. Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 6400 Sw Canyon Ct, Ste 100, Portland, OR 97221 Phone: 503-477-9616 Fax: 503-477-9808 | |
Donald Richard Sullivan, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 3181 Sw Sam Jackson Park Rd, Uhn67, Portland, OR 97239 Phone: 503-494-6949 | |
Dr. Victor Nguyen Pham, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 9205 Sw Barnes Rd, Portland, OR 97225 Phone: 503-216-2906 | |
Richa Uppal, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 800 Sw 13th Ave, Portland, OR 97205 Phone: 503-221-0161 Fax: 503-274-1697 | |
Reem Hasan, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 3181 Sw Sam Jackson Park Rd, Ppv 350, Portland, OR 97239 Phone: 503-494-8562 |